TY - JOUR
T1 - Infragenicular polytetrafluoroethylene bypass with distal vein cuffs for limb salvage
T2 - A contemporary series
AU - Lauterbach, Stephen R.
AU - Torres, Gustavo A.
AU - Andros, George
AU - Oblath, Robert W.
AU - Valentine, R. James
AU - Debord, James
AU - Hans, Sachinder
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2005/5
Y1 - 2005/5
N2 - Hypothesis: Infragenicular polytetrafluoroethylene (PTFE)-venous cuff bypass grafting provides acceptable graft patency and limb salvage rates for limb salvage. Design: Retrospective clinical review of a consecutive series. Setting: Vascular surgical practice during the interval October 1, 2000, to September 1, 2004. Patients: Fifty-one male and 49 female patients whose mean age was 76.9 years were operated on for tissue loss (67%), chronic rest pain (28%), and severe claudication (6%). Fifty-two percent of patients were diabetic and 49% had undergone previous leg bypass surgery. All patients had absent or inadequate greater saphenous vein, and 84 patients had absent or inadequate arm vein. Interventions: One hundred five infragenicular PTFE bypasses were performed in these 100 patients. Distal targets were the infragenicular popliteal (40), posterior tibial (35), anterior tibial (16), and peroneal arteries (14). Sixty-eight venous cuffs were constructed from lesser saphenous vein. Main Outcome Measures: Graft patency, limb salvage, and patient survival were analyzed. Results: Twelve early graft failures resulted in 7 leg amputations. The mean ± SE 3-year primary patency and limb salvage rates were 64.4% ± 12.8% and 74.4% ± 11.9%, respectively. Perioperative mortality was 2.9% and 3-year survival was 38%. Graft follow-up ranged from 1 to 47 months with a mean of 13 months using life-table methods. Conclusions: For patients requiring arterial revascularization for limb salvage, in which autologous venous conduit is unavailable, distal venous cuff-PTFE bypass provides acceptable patency and limb salvage rates when viewed in the context of short life expectancy for these elderly patients.
AB - Hypothesis: Infragenicular polytetrafluoroethylene (PTFE)-venous cuff bypass grafting provides acceptable graft patency and limb salvage rates for limb salvage. Design: Retrospective clinical review of a consecutive series. Setting: Vascular surgical practice during the interval October 1, 2000, to September 1, 2004. Patients: Fifty-one male and 49 female patients whose mean age was 76.9 years were operated on for tissue loss (67%), chronic rest pain (28%), and severe claudication (6%). Fifty-two percent of patients were diabetic and 49% had undergone previous leg bypass surgery. All patients had absent or inadequate greater saphenous vein, and 84 patients had absent or inadequate arm vein. Interventions: One hundred five infragenicular PTFE bypasses were performed in these 100 patients. Distal targets were the infragenicular popliteal (40), posterior tibial (35), anterior tibial (16), and peroneal arteries (14). Sixty-eight venous cuffs were constructed from lesser saphenous vein. Main Outcome Measures: Graft patency, limb salvage, and patient survival were analyzed. Results: Twelve early graft failures resulted in 7 leg amputations. The mean ± SE 3-year primary patency and limb salvage rates were 64.4% ± 12.8% and 74.4% ± 11.9%, respectively. Perioperative mortality was 2.9% and 3-year survival was 38%. Graft follow-up ranged from 1 to 47 months with a mean of 13 months using life-table methods. Conclusions: For patients requiring arterial revascularization for limb salvage, in which autologous venous conduit is unavailable, distal venous cuff-PTFE bypass provides acceptable patency and limb salvage rates when viewed in the context of short life expectancy for these elderly patients.
UR - http://www.scopus.com/inward/record.url?scp=18144381539&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=18144381539&partnerID=8YFLogxK
U2 - 10.1001/archsurg.140.5.487
DO - 10.1001/archsurg.140.5.487
M3 - Review article
C2 - 15897445
AN - SCOPUS:18144381539
SN - 2168-6254
VL - 140
SP - 487
EP - 494
JO - JAMA Surgery
JF - JAMA Surgery
IS - 5
ER -